12-month outcomes of GLP - 1 in severe pediatric obesity: real-world data
Liraglutide was effective and safe in reducing adiposity and improving metabolic health in children and adolescents with severe obesity in a real-world setting.
Authors
- Michel Longatti de Resende
- Gustavo Neme (ORCID: https://orcid.org/0000-0001-5874-3550)
- Louise Cominato (ORCID: https://orcid.org/0000-0001-9752-1117)
- Ruth Rocha Franco (ORCID: https://orcid.org/0000-0001-5811-7656)
- Claudia Renata Pinto dos Santos
- Sonia Fátima Leal de Souza (ORCID: https://orcid.org/0000-0001-6961-3444)
- Ludmila L. Rachid
- Durval Damiani (ORCID: https://orcid.org/0000-0002-2748-4442)
- Larissa Baldini Farjalla Mattar
- Caroline Passone (ORCID: https://orcid.org/0000-0001-7981-3335)
- Nayanne Maria Costa Bernardes
Institutions
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-09-19
- DOI
- https://doi.org/10.3389/fendo.2025.1663499
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.88